Annual Working Capital:
$526.80M+$181.83M(+52.71%)Summary
- As of today, RXRX annual working capital is $526.80 million, with the most recent change of +$181.83 million (+52.71%) on December 31, 2024.
- During the last 3 years, RXRX annual working capital has risen by +$38.74 million (+7.94%).
- RXRX annual working capital is now at all-time high.
Performance
RXRX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Working Capital:
$423.13M-$19.03M(-4.30%)Summary
- As of today, RXRX quarterly working capital is $423.13 million, with the most recent change of -$19.03 million (-4.30%) on June 30, 2025.
- Over the past year, RXRX quarterly working capital has dropped by -$13.16 million (-3.02%).
- RXRX quarterly working capital is now -31.54% below its all-time high of $618.10 million, reached on June 30, 2021.
Performance
RXRX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
RXRX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +52.7% | -3.0% |
| 3Y3 Years | +7.9% | -5.8% |
| 5Y5 Years | +655.6% | - |
RXRX Working Capital Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +52.7% | -19.7% | +56.9% |
| 5Y | 5-Year | at high | +655.6% | -31.5% | +117.0% |
| All-Time | All-Time | at high | +655.6% | -31.5% | +117.0% |
RXRX Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $423.13M(-4.3%) |
| Mar 2025 | - | $442.16M(-16.1%) |
| Dec 2024 | $526.80M(+52.7%) | $526.80M(+44.2%) |
| Sep 2024 | - | $365.28M(-16.3%) |
| Jun 2024 | - | $436.29M(+61.8%) |
| Mar 2024 | - | $269.69M(-21.8%) |
| Dec 2023 | $344.97M(-26.5%) | $344.97M(+11.8%) |
| Sep 2023 | - | $308.50M(-0.5%) |
| Jun 2023 | - | $309.96M(-21.1%) |
| Mar 2023 | - | $392.77M(-16.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $469.55M(-3.8%) | $469.55M(+17.8%) |
| Sep 2022 | - | $398.58M(-11.3%) |
| Jun 2022 | - | $449.34M(-15.8%) |
| Mar 2022 | - | $533.75M(+9.4%) |
| Dec 2021 | $488.06M(+100.6%) | $488.06M(-12.5%) |
| Sep 2021 | - | $557.93M(-9.7%) |
| Jun 2021 | - | $618.10M(+217.0%) |
| Mar 2021 | - | $194.97M(-19.9%) |
| Dec 2020 | $243.34M(+249.1%) | - |
| Dec 2020 | - | $243.34M |
| Dec 2019 | $69.71M | - |
FAQ
- What is Recursion Pharmaceuticals, Inc. annual working capital?
- What is the all-time high annual working capital for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. annual working capital year-on-year change?
- What is Recursion Pharmaceuticals, Inc. quarterly working capital?
- What is the all-time high quarterly working capital for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. quarterly working capital year-on-year change?
What is Recursion Pharmaceuticals, Inc. annual working capital?
The current annual working capital of RXRX is $526.80M
What is the all-time high annual working capital for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high annual working capital is $526.80M
What is Recursion Pharmaceuticals, Inc. annual working capital year-on-year change?
Over the past year, RXRX annual working capital has changed by +$181.83M (+52.71%)
What is Recursion Pharmaceuticals, Inc. quarterly working capital?
The current quarterly working capital of RXRX is $423.13M
What is the all-time high quarterly working capital for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high quarterly working capital is $618.10M
What is Recursion Pharmaceuticals, Inc. quarterly working capital year-on-year change?
Over the past year, RXRX quarterly working capital has changed by -$13.16M (-3.02%)